FDA approves Alzheimer’s drug that slowed cognitive decline in clinical trial

The FDA's decision comes after clinical trial results indicated that lecanemab slows cognitive decline somewhat in people with mild impairment

Read more

Stocks making the biggest moves midday: Mission Produce, Nutanix, Alphabet, Tesla and more

These are the stocks posting the largest moves in midday trading. Source link

Read more

Jim Cramer’s top 10 things to watch in the market Wednesday: Fed’s Powell, data on Alzheimer’s drug, tech earnings

It's the last day of November, and the Dow and S&P 500 are poised to log their second straight month

Read more

We’re increasing price targets on 3 of our stocks, including 2 crushing the boarder market

Following our price target changes on eight Club holdings last month, we're updating three more Tuesday. Source link

Read more

Earnings could be an even bigger catalyst for stocks after the market’s wild ride on rate fears

Investors are likely to switch their focus to earnings season, after the market's wild ride on rising and falling expectations

Read more

Here are Monday’s biggest analyst calls of the day: Biogen, Wendy’s, Sirius XM, Amazon & more

Here are the biggest calls on Wall Street on Source link

Read more